Cargando…
Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage
Edaravone dexborneol is a novel neuroprotective drug that comprises edaravone and (+)-borneol in a 4:1 ratio. Phase II and III studies have demonstrated that Chinese patients treated with edaravone dexborneol within 48 h of AIS onset have better functional outcomes than those treated with edaravone...
Autores principales: | Chen, Qian, Cai, Yichen, Zhu, Xiaoyu, Wang, Jing, Gao, Feng, Yang, Mingfeng, Mao, Leilei, Zhang, Zongyong, Sun, Baoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068884/ https://www.ncbi.nlm.nih.gov/pubmed/35529450 http://dx.doi.org/10.3389/fphar.2022.848529 |
Ejemplares similares
-
Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022) -
Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO‐1 signaling pathway in mice
por: Xu, Lili, et al.
Publicado: (2022) -
Effects of edaravone dexborneol on neurological function and serum inflammatory factor levels in patients with acute anterior circulation large vessel occlusion stroke
por: Hu, Xiaohong, et al.
Publicado: (2023) -
Edaravone combined with cinepazide maleate on neurocyte autophagy and neurological function in rats with subarachnoid hemorrhage
por: Cai, Zhenli, et al.
Publicado: (2020) -
Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Li, Keliang, et al.
Publicado: (2022)